Analyst group logo

Latest news

Video

2024-06-28

Intervju med Refine Groups VD David Wallinder
Read more

Comment

2024-06-26

Comment on ODI Pharma’s Strategic Market Entry to Switzerland
Read more

Analysis

2024-06-18

Refine Group
Read more

Analysis

2024-06-18

Syncro Group Q1-24
Read more

Analysis

2024-06-18

Vultus
Read more

Comment

2024-06-17

Comment on STENOCARE’s Expansion into Canada
Read more

Analysis

2024-06-17

Luxbright
Read more

Comment

2024-06-14

Kommentar på Luxbrights annonserade företrädesemission om ca 15 MSEK
Read more

Comment

2024-06-12

Kommentar på CirChems treåriga avtal med en ledande fordonstillverkare värt lägst 13,2 MSEK
Read more

Rights Issue

2024-06-11

TO: STENOCARE
Read more

Text interview

2024-06-10

Interview with Magnora’s CEO Erik Sneve
Read more

Analysis

2024-06-10

Kinda Brave
Read more

Comment

2024-06-10

Kommentar på CirChems största enskilda order genom ett nytt samarbete med Stena Recycling Danmark
Read more

Analysis

2024-06-07

Huddlestock Q1-24
Read more

Analysis

2024-06-05

Lucky Games Q1-24
Read more

Analysis

2024-06-05

ODI Pharma Q1-24
Read more

Analysis

2024-06-05

Windon Energy Group Q1-24
Read more

Analysis

2024-06-04

NOSIUM Q1-24
Read more

Comment

2024-06-03

Kommentar på Zoomabilitys senaste kapitaltillskott
Read more

Comment

2024-06-03

Analyst Group kommenterar Windons lansering av de första demoanläggningarna för RidgeBlade
Read more

Comment

2024-06-03

Kommentar på Lucky Games rapport
Read more

Comment

2024-05-30

Comment on ODI Pharma’s Quarterly Report
Read more

Comment

2024-05-30

Kommentar på Syncro Groups Q1-rapport
Read more

Comment

2024-05-30

Comment on Huddlestocks’s Q1-24 Report
Read more

Comment

2024-05-30

Kommentar på Windon Energy Groups Q1-rapport
Read more

Comment

2024-05-30

Kommentar på Luxbrights samarbete med L3Harris värt över 15 MSEK
Read more

Comment

2024-05-30

Kommentar på CirChems refinansiering
Read more

Comment

2024-05-28

Kommentar på Nosiums Q1-rapport
Read more

Video

2024-05-24

Intervju med Zoomabilitys VD Pehr-Johan Fager
Read more

Analysis

2024-05-24

ChargePanel Q1-24
Read more

Comment

2024-05-23

Comment on STENOCARE Launching Next Generation Medical Cannabis Oil Product in Australia
Read more

Analysis

2024-05-23

Zoomability Q1-24
Read more

Text interview

2024-05-23

Interview with Vistin Pharma’s CEO Magnus Tolleshaug and CFO Alexander Karlsen
Read more

Analysis

2024-05-23

Björn Borg Q1-24
Read more

Analysis

2024-05-21

First Venture Q1-24
Read more

Analysis

2024-05-21

EcoRub Q1-24
Read more

Analysis

2024-05-21

CirChem Q1-24
Read more

Rights Issue

2024-05-21

Emission: Biofrigas
Read more

Analysis

2024-05-21

Biofrigas
Read more

Analysis

2024-05-20

Tangiamo Touch Q1-24
Read more

Comment

2024-05-20

Analyst Group inleder analysbevakning på Luxbright
Read more

Analysis

2024-05-20

Lyckegård Group Q1-24
Read more

Analysis

2024-05-20

Pharma Equity Group Q1-24
Read more

Comment

2024-05-17

Comment on Björn Borgs Q1 Report for 2024
Read more

Analysis

2024-05-17

Arctic Blue Beverages Q1-24
Read more

Comment

2024-05-16

Comment on PEG’s Q1 Report for 2024
Read more

Comment

2024-05-16

Kommentar på First Ventures Q1-rapport
Read more

Analysis

2024-05-16

TCECUR Q1-24
Read more

Comment

2024-05-16

Kommentar på Zoomabilitys Q1-rapport
Read more

Comment

2024-05-15

Kommentar på Arctic Blue Beverages Q1-rapport
Read more

Analysis

2024-05-15

Obducat Q1-24
Read more

Analysis

2024-05-15

MTI Investment
Read more

Comment

2024-05-14

Kommentar på ChargePanels Q1-rapport
Read more

Video

2024-05-14

Intervju med MTI Investments VD Pontus Engström
Read more

Comment

2024-05-14

Kommentar på CirChems Q1-rapport
Read more

Comment

2024-05-14

Kommentar på TCECURs Q1-rapport
Read more

Rights Issue

2024-05-13

TO: MTI Investment
Read more

Comment

2024-05-13

Kommentar på Lyckegårds Q1-rapport
Read more

Comment

2024-05-10

Kommentar på Tangiamos Q1-rapport
Read more

Text interview

2024-05-08

Interview with Verkkokauppa.com’s Head of Investor Relations Marja Mäkinen
Read more

Rights Issue

2024-05-08

IPO: Kinda Brave
Read more

Analysis

2024-05-08

Kinda Brave
Read more

Analysis

2024-05-08

STENOCARE Q1-24
Read more

Comment

2024-05-06

Kommentar på SDS Q1-rapport 2024
Read more

Text interview

2024-05-06

Interview with Omda’s CFO Einar Bonnevie
Read more

Analysis

2024-05-06

ODI Pharma
Read more

Video

2024-05-06

Interview with ODI Pharma’s Chairman of the Board Volker Wiederrich
Read more

Comment

2024-05-06

Kommentar på Obducats Q1-rapport
Read more

Comment

2024-05-03

Analyst Group kommenterar MTI Investments avtal om att utöka ägarandelen i FinTech Africa AB
Read more

Comment

2024-05-03

Kommentar på EcoRubs Q1-rapport
Read more

Comment

2024-05-02

Comment on STENOCARE’s Q1-report Report 2024
Read more

Analysis

2024-05-02

AcuCort Q1-24
Read more

Analysis

2024-05-02

Cardeon
Read more

Comment

2024-05-01

Analyst Group kommenterar MTI Investments nya aktieägarlån till AML Finance Limited
Read more

Comment

2024-04-29

Kommentar på Zoomabilitys finansierings- och licensavtal med Unidaco
Read more

Comment

2024-04-26

Kommentar på AcuCorts Q1-rapport
Read more

Text interview

2024-04-25

Interview with Huddly’s CFO Abhijit Saha Banik
Read more

Text interview

2024-04-24

Intervju med Guideline Geos VD Malin Siberg
Read more

Comment

2024-04-24

Kommentar på Mavens produktionsavtal med Vexos Inc.
Read more

Analysis

2024-04-23

Lyckegård Group
Read more

Newsletter

Subscribe to be the first to get our news and latest reports